Skip to content

Equinovarus foot function after stroke

Effect of surgery on foot function in the management of equinovarus foot deformity following stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON20535
Enrollment
20
Registered
2016-07-14
Start date
2016-10-20
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

equinovarus foot stroke foot and ankle kinematics soft tissue surgery

Interventions

The measurements will take place befor and after standard soft-tissue surgery

Sponsors

Ir. Miriam Luizink (director) Roessingh Research and Development Roessinghsbleekweg 33 b 7522 AH Enschede The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Unilateral ischaemic or haemorrhagic hemiparetic stroke 2. Time since stroke > 6 months 3. Age 18 years or older 4. Walking disabilities and/or fall incidents and/or pressure sores on the foot and/or unable to walk bare foot due to structural or dynamic equinovarus foot deformity, including a. problems with stability in stance b. problems with foot clearance during swing c. problems with foot prepositioning in early stance 5. Subject is able to participate in an 1.5 hour session, including several stand and walking activities (walking aids allowed) with breaks in-between

Exclusion criteria

Exclusion criteria: 1. Complicating medical history such as cardiac, pulmonary, neurological or orthopaedic disorders that could affect performance of the included measurements 2. Neurolysis (fenol/alcohol) < 8 months 3. Motorpoint blockage (btx) < 5 months 4. Suffering from severe neglect 5. Severe comprehensive aphasia 6. Severe cognitive disorders

Design outcomes

Primary

MeasureTime frame
Lower extremity body motion (kinematics) during gait

Secondary

MeasureTime frame
FUNCTION • Forceplate: The body loading (kinetics) during gait . • Motricity Index, lower extremity: rapid overall indication of limb impairment and a validated measure for strength of the lower extremity • Ankle dorsiflexor muscle strength will be assessed by means of a hand-held dynamometer. • The muscle activation patterns of the leg and foot muscles v WALKING ABILITY • Timed Balance Test • Timed Up and Go (TUG) • L-test • 10 meter walk test (10 m WT) • 6 minute walk test (6 minWT) to assess walking endurance [Kosak 2005, Tyson 2009]. • Foot and Ankle Ability Measure (FAAM) to assess the ability and difficulty to walk and stand during various daily activities • Barefoot mobility, 3 questions will be included to assess ability and difficulty to walk bare foot while getting in and out of the bed, walking to the toilet and personal care. • Rate of perceived Exertion (RPE or Borg scale) is scored for the L-test barefoot and for the 6 min WT (wearing shoes) • Functional Gait Assessment (FGA) • Functional Ambulation Categories (FAC) to assess the level of physical support needed to walk safely and to assess where the participant can walk. PARTICIPATION • Three patient specific complaints (PSK’s) are assessed and scored on a visual analogue scale (VAS) with each a maximum score of 100 points. • Stroke Impact Scale (SIS) version 3.0 to assess impairments and quality of life . • Nottingham Extended ADL to assess the ability to independently perform activities in daily life regarding mobility, kitchen activities, household and recreation. • Falls Efficacy Scale International (short-FES-I)

Contacts

Public ContactRosemary Dubbeldam

Postbus 310

r.dubbeldam@rrd.nl+31 (0)53 4875700

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)